Evaluation of the risk of occupational exposure to antineoplastic drugs in healthcare sector: part II – the application of the FMECA method to compare manual vs automated preparation
This work is licensed under the Creative Commons Attribution 4.0 International License.
Institute for Safe Medication Practices (ISIMP). ISMP list of high-alert medications in acute care settings [displayed 7 March 2024]. Available at
https://www.ismp.org/sites/default/files/attachments/2018-08/highAlert2018-Acute-Final.pdfInstitute for Safe Medication Practices (ISIMP)Available at
https://www.ismp.org/sites/default/files/attachments/2018-08/highAlert2018-Acute-Final.pdfSearch in Google Scholar
Carrez L, Falaschi L, Cingria L, Sadeghipour F, Bouchoud L, Bonnabry P. [Organisation et sécurisation du circuit des chimiothérapies: Exemple de la pharmacie des Hôpitaux Universitaires de Genève, in French]. Pharmactuel 2014;47:119–24.CarrezLFalaschiLCingriaLSadeghipourFBouchoudLBonnabryP[Organisation et sécurisation du circuit des chimiothérapies: Exemple de la pharmacie des Hôpitaux Universitaires de Genève, in French]20144711924Search in Google Scholar
Palma E, Bufarini C. Robotized compounding of oncology drugs in a hospital pharmacy. Int J Pharm Compd 2014;18:358–64. PMID: 25577883PalmaEBufariniCRobotized compounding of oncology drugs in a hospital pharmacy2014183586425577883Search in Google Scholar
Hon C-Y, Teschke K, Chua P, Venners S, Nakashima L. Occupational exposure to antineoplastic drugs: identification of job categories potentially exposed throughout the hospital medication system. Saf Health Work 2011;2(3):273–81. doi: 10.5491/SHAW.2011.2.3.273HonC-YTeschkeKChuaPVennersSNakashimaLOccupational exposure to antineoplastic drugs: identification of job categories potentially exposed throughout the hospital medication system2011232738110.5491/SHAW.2011.2.3.273Open DOISearch in Google Scholar
Ndaw S, Remy A. Occupational exposure to antineoplastic drugs in twelve French health care setting: biological monitoring and surface contamination. Int J Environ Res Public Health 2023;20(6):4952. doi: 10.3390/ijerph20064952NdawSRemyAOccupational exposure to antineoplastic drugs in twelve French health care setting: biological monitoring and surface contamination2023206495210.3390/ijerph20064952Open DOISearch in Google Scholar
Mucci N, Dugheri S, Farioli A, Garzaro G, Rapisarda V, Campagna M, Bonari A, Arcangeli G. Occupational exposure to antineoplastic drugs in hospital environments: potential risk associated with contact with cyclophosphamide- and ifosfamide-contaminated surfaces. Med Pr 2020;71:519–29. doi: 10.13075/mp.5893.00931MucciNDugheriSFarioliAGarzaroGRapisardaVCampagnaMBonariAArcangeliGOccupational exposure to antineoplastic drugs in hospital environments: potential risk associated with contact with cyclophosphamide- and ifosfamide-contaminated surfaces2020715192910.13075/mp.5893.00931Open DOISearch in Google Scholar
Dugheri S, Mucci N, Mini E, Cappelli G, Bucaletti E, Squillaci D, Trevisani L, Arcangeli G. An update on permeation of protective medical gloves by antineoplastic drugs. Sigurnost 2022;64:341–57. doi: 10.31306/s.64.4.2DugheriSMucciNMiniECappelliGBucalettiESquillaciDTrevisaniLArcangeliGAn update on permeation of protective medical gloves by antineoplastic drugs2022643415710.31306/s.64.4.2Open DOISearch in Google Scholar
Korczowska E, Jankowiak-Gracz H, Crul M, Tuerk J, Arnold D, Meier K. Surface contamination with cytotoxic drugs in european hospital wards. Eur J Hosp Pharm 2020;27(Suppl 1):A41.KorczowskaEJankowiak-GraczHCrulMTuerkJArnoldDMeierKSurface contamination with cytotoxic drugs in european hospital wards202027Suppl 1A41Search in Google Scholar
Falck K, Gröhn P, Sorsa M, Vainio H, Heinonen E, Holsti LR. Mutagenicity in urine of nurses handling cytostatic drugs. Lancet 1979;313:1250–1. doi: 10.1016/s0140-6736(79)91939-1FalckKGröhnPSorsaMVainioHHeinonenEHolstiLRMutagenicity in urine of nurses handling cytostatic drugs19793131250110.1016/s0140-6736(79)91939-1Open DOISearch in Google Scholar
Nurse24.it. Manipolazione farmaci antiblastici: Uno sguardo al futuro [Handling antineoplastic pharmaceuticals: a look at the future, in Italian] [displayed 20 August 2023]. Available at
https://www.nurse24.it/infermiere/farmaci/antiblastici-manipolazione-rischi-infermiere.htmlNurse24.itAvailable at https://www.nurse24.it/infermiere/farmaci/antiblastici-manipolazione-rischi-infermiere.htmlSearch in Google Scholar
AboutPharma. Preparazione di farmaci antiblastici, quadro ancora frammentato in Italia: “serve fare rete” [Preparation of antineoplastic pharmaceuticals, still a fragmented picture in Italy: needs creating a net, in Italian] [displayed 20 August 2023]. Available at
https://www.aboutpharma.com/business-e-mercato/preparazione-farmaciantiblastici-quadro-ancora-frammentato-italia-serve-rete/AboutPharma[displayed 20 August 2023]. Available at
https://www.aboutpharma.com/business-e-mercato/preparazione-farmaciantiblastici-quadro-ancora-frammentato-italia-serve-rete/Search in Google Scholar
Adade CA, Benabbes M, Belahcen MJ, Rahali Y. Centralization impact and cost-saving study in a Moroccan hospital’s centralized unit of chemotherapy preparation. J Oncol Pharm Pract 2020;26:1630–6. doi: 10.1177/1078155220901336AdadeCABenabbesMBelahcenMJRahaliYCentralization impact and cost-saving study in a Moroccan hospital’s centralized unit of chemotherapy preparation2020261630610.1177/1078155220901336Open DOISearch in Google Scholar
Notiziario Chimico Farmaceutico. [UFA: Unità Farmaci Antiblastici, in Italian] [displayed 20 August 2023]. Available at
https://www.notiziariochimicofarmaceutico.it/2017/09/04/migliorare-la-gestionedelle-ufa/Notiziario Chimico Farmaceutico[displayed 20 August 2023]. Available at https://www.notiziariochimicofarmaceutico.it/2017/09/04/migliorare-la-gestionedelle-ufa/Search in Google Scholar
HTA Focus. Pills of Clinical Governance 2017;4(2):55–120 [displayed 20 August 2023]. Available at
https://www.htafocus.it/pdfvol4-n2-2017HTA Focus20174255120[displayed 20 August 2023]. Available at
https://www.htafocus.it/pdfvol4-n2-2017Search in Google Scholar
Farmacia Ospedaliera. [Rapporto tra numero di preparati allestiti al giorno, personale necessario e costo per preparato nelle UFA, in Italian] [displayed 20 August 2023]. Available at
https://www.farmaciaospedaliera.it/rapporto-tra-numero-di-preparati-allestiti-algiorno-personale-necessario-e-costo-per-preparato-nelle-ufa/Farmacia Ospedaliera[displayed 20 August 2023]. Available at https://www.farmaciaospedaliera.it/rapporto-tra-numero-di-preparati-allestiti-algiorno-personale-necessario-e-costo-per-preparato-nelle-ufa/Search in Google Scholar
Cote DD, Torchia MG. Robotic system for i.v. antineoplastic drug preparation: description and preliminary evaluation under simulated conditions. Am J Hosp Pharm 1989;46:2286–93. PMID: 2589345CoteDDTorchiaMGRobotic system for i.v. antineoplastic drug preparation: description and preliminary evaluation under simulated conditions1989462286932589345Search in Google Scholar
Fox BI, Felkey BG. Automated intravenous preparation: robots for the pharmacy. Hosp Pharm 2009;44:255–7. doi: 10.1310/hpj4403-255FoxBIFelkeyBGAutomated intravenous preparation: robots for the pharmacy200944255710.1310/hpj4403-255Open DOISearch in Google Scholar
Schoening T, Artes A, Ehmann M, Mertens M, Ober M, Hoppe-Tichy T. Semiautomated aseptic preparation of patient-individual antineoplastic intravenous solutions: first experiences in a German hospital pharmacy. Eur J Hosp Pharm 2016;23:44–9. doi: 10.1136/ejhpharm-2015-000655SchoeningTArtesAEhmannMMertensMOberMHoppe-TichyTSemiautomated aseptic preparation of patient-individual antineoplastic intravenous solutions: first experiences in a German hospital pharmacy20162344910.1136/ejhpharm-2015-000655Open DOISearch in Google Scholar
Schierl R, Masini C, Groeneveld S, Fischer E, Böhlandt A, Rosini V, Paolucci D. Environmental contamination by cyclophosphamide preparation: Comparison of conventional manual production in biological safety cabinet and robot-assisted production by APOTECAchemo. J Oncol Pharm Pract 2014;22:37–45. doi: 10.1177/1078155214551316SchierlRMasiniCGroeneveldSFischerEBöhlandtARosiniVPaolucciDEnvironmental contamination by cyclophosphamide preparation: Comparison of conventional manual production in biological safety cabinet and robot-assisted production by APOTECAchemo201422374510.1177/1078155214551316Open DOISearch in Google Scholar
Carrez L, Martin V, Verrey A, Furrer P, Bouchoud L, Falaschi L, Bonnabry P. Qualification and performance evaluation of an automated system for compounding injectable cytotoxic drugs. Pharm Technol Hosp Pharm 2018;3:165–75. doi: 10.1515/pthp-2018-0012CarrezLMartinVVerreyAFurrerPBouchoudLFalaschiLBonnabryPQualification and performance evaluation of an automated system for compounding injectable cytotoxic drugs201831657510.1515/pthp-2018-0012Open DOISearch in Google Scholar
Yaniv AW, Knoer SJ. Implementation of an i.v.-compounding robot in a hospital-based cancer center pharmacy. Am J Health Syst Pharm 2013;70:2030–7. doi: 10.2146/ajhp120649YanivAWKnoerSJImplementation of an i.v.-compounding robot in a hospital-based cancer center pharmacy2013702030710.2146/ajhp120649Open DOISearch in Google Scholar
Masini C, Nanni O, Antaridi S, Gallegati D, Marri M, Paolucci D, Minguzzi M, Altini M. Automated preparation of chemotherapy: quality improvement and economic sustainability. Am J Health Syst Pharm 2014;71:579–85. doi: 10.2146/ajhp130489MasiniCNanniOAntaridiSGallegatiDMarriMPaolucciDMinguzziMAltiniMAutomated preparation of chemotherapy: quality improvement and economic sustainability2014715798510.2146/ajhp130489Open DOISearch in Google Scholar
Nurgat Z, Faris D, Mominah M, Vibar A, Al-Jazairi A, Ewing S, Ashour M, Qaisi SK, Balhareth S, Al-Jedai A. A three-year study of a first-generation chemotherapy-compounding robot. Am J Health Syst Pharm 2015;72:1036–45. doi: 10.2146/ajhp140256NurgatZFarisDMominahMVibarAAl-JazairiAEwingSAshourMQaisiSKBalharethSAl-JedaiAA three-year study of a first-generation chemotherapy-compounding robot20157210364510.2146/ajhp140256Open DOISearch in Google Scholar
Foglia E, Asperti F, Bellavia D, Schettini F, Cecchi A, Morassutto C. Unità Farmaci Antitumorali: modelli organizzativi e logistici a confronto. Uno studio condotto in Friuli-Venezia Giulia ha analizzato diversi scenari per definire il setting organizzativo e logistico maggiormente efficiente per la preparazione di agenti chemioterapici [Antitumour Drug Union: facing organisational and logistical models, in Italian] [displayed 20 August 2023]. Available at
https://trendsanita.it/unita-farmaci-antitumorali-organizzazione-logistica/FogliaEAspertiFBellaviaDSchettiniFCecchiAMorassuttoC[displayed 20 August 2023]. Available at
https://trendsanita.it/unita-farmaci-antitumorali-organizzazione-logistica/Search in Google Scholar
American Society of Health-System Pharmacists. ASHP guidelines on handling hazardous drugs. Am J Health Syst Pharm 2006;63:1172–93.American Society of Health-System PharmacistsASHP guidelines on handling hazardous drugs200663117293Search in Google Scholar
International Society of Oncology Pharmacy Practicioners Standards Committee. ISOPP standards of practice. Safe handling of cytotoxics. J Oncol Pharm Pract 2007;13(Suppl):1–81. doi: 10.1177/1078155207082350International Society of Oncology Pharmacy Practicioners Standards CommitteeISOPP standards of practice. Safe handling of cytotoxics200713Suppl18110.1177/1078155207082350Open DOISearch in Google Scholar
European Agency for Safety and Health at Work. Guidance for the safe management of hazardous medicinal products at work [displayed 20 August 2023]. Available at https://osha.europa.eu/en/publications/guidance-safe-management-hazardous-medicinal-products-workEuropean Agency for Safety and Health at Work[displayed 20 August 2023]. Available at https://osha.europa.eu/en/publications/guidance-safe-management-hazardous-medicinal-products-workSearch in Google Scholar
Yeh TM, Chen LY. Fuzzy-based risk priority number in FMEA for semiconductor wafer processes. Int J Prod Res 2014;52:539–49. doi: 10.1080/00207543.2013.837984YehTMChenLYFuzzy-based risk priority number in FMEA for semiconductor wafer processes2014525394910.1080/00207543.2013.837984Open DOISearch in Google Scholar
Jiang Y, Jiang H, Ding S, Liu Q. Application of failure mode and effects analysis in a clinical chemistry laboratory. Clin Chim Acta Int J Clin Chem 2015;448:80–5. doi: 10.1016/j.cca.2015.06.016JiangYJiangHDingSLiuQApplication of failure mode and effects analysis in a clinical chemistry laboratory201544880510.1016/j.cca.2015.06.016Open DOISearch in Google Scholar
Lago P, Bizzarri G, Scalzotto F, Parpaiola A, Amigoni A, Putoto G, Perilongo G. Use of FMEA analysis to reduce risk of errors in prescribing and administering drugs in paediatric wards: a quality improvement report. BMJ Open 2012;2:e001249. doi:10.1136/bmjopen-2012-001249LagoPBizzarriGScalzottoFParpaiolaAAmigoniAPutotoGPerilongoGUse of FMEA analysis to reduce risk of errors in prescribing and administering drugs in paediatric wards: a quality improvement report20122e00124910.1136/bmjopen-2012-001249Open DOISearch in Google Scholar
Cherif Chefchaouni A, Boudina Y, Chennaq M, Belahcen MJ, Rahali Y. Contribution of an anticancer drug compounding robot in reducing the risks of manual preparation in a hospital pharmacy unit specialized in oncology. J Oncol Pharm Pract 2023;29:1334–42. doi: 10.1177/10781552221118846Cherif ChefchaouniABoudinaYChennaqMBelahcenMJRahaliYContribution of an anticancer drug compounding robot in reducing the risks of manual preparation in a hospital pharmacy unit specialized in oncology20232913344210.1177/10781552221118846Open DOISearch in Google Scholar
Bhirich N, Chefchaouni AC, Medkouri SE, Shytry O, Belahcen MJ, Rahali Y. Risk assessment of personnel exposure in a central cytotoxic preparation unit using the FMECA method. J Oncol Pharm Pract 2023;29:1884–92. doi: 10.1177/10781552231153625BhirichNChefchaouniACMedkouriSEShytryOBelahcenMJRahaliYRisk assessment of personnel exposure in a central cytotoxic preparation unit using the FMECA method20232918849210.1177/10781552231153625Open DOISearch in Google Scholar
Zribi K, Minh Mai Le L, Rajkumar A, Aboudagga H, Frikha M, Dietrich A, Zribi E, Safta F, Caudron E. Antineoplastic drug handling: higher risk for healthcare workers in Tunisia than in France? Biomed Environ Sci 2020;33:803–6. doi: 10.3967/bes2020.108ZribiKMinh Mai LeLRajkumarAAboudaggaHFrikhaMDietrichAZribiESaftaFCaudronEAntineoplastic drug handling: higher risk for healthcare workers in Tunisia than in France?202033803610.3967/bes2020.108Open DOISearch in Google Scholar
Dugheri S, Squillaci D, Cappelli G, Saccomando V, Fanfani N, Ceccarelli J, Mucci N, Arcangeli G. Evaluation of the risk of occupational exposure to antineoplastic drugs in healthcare sector: part I – medical gloves. Arh Hig Rada Toksikol 2023;74:187–97. doi: 10.2478/aiht-2023-74-3734DugheriSSquillaciDCappelliGSaccomandoVFanfaniNCeccarelliJMucciNArcangeliGEvaluation of the risk of occupational exposure to antineoplastic drugs in healthcare sector: part I – medical gloves2023741879710.2478/aiht-2023-74-3734Open DOISearch in Google Scholar
Gilpin WR, Powitz WR. NSF International NSF 49-2019 Informative Annex 1 (formerly Annex E) Biosafety cabinet selection, installation, use, lifespan and decommissioning [technical report 2020 NSF NSF/ANSI 49-2019]. doi: 10.13140/RG.2.2.31444.96645GilpinWRPowitzWR10.13140/RG.2.2.31444.96645Open DOISearch in Google Scholar
European Commission (EC). The rules governing medical products in the European Union volume 4 EU guidelines for good manufacturing practice for medical products for human and veterinary use [displayed 7 March 2024]. Available at:
https://health.ec.europa.eu/document/download/e05af55b-38e9-42bf-8495-194bbf0b9262_en?filename=20220825_gmp-an1_en_0.pdfEuropean Commission (EC)Available at: https://health.ec.europa.eu/document/download/e05af55b-38e9-42bf-8495-194bbf0b9262_en?filename=20220825_gmp-an1_en_0.pdfSearch in Google Scholar
Heloury J, Bougeon G, Deljehier T, Jourand A, Berroneau A, Crauste-Manciet S. Automation of aseptic sterile preparation: risk analysis and productivity comparison with manual process. Pharm Technol Hosp Pharm 2019;4:15–28. doi: 10.1515/pthp-2019-0001HelouryJBougeonGDeljehierTJourandABerroneauACrauste-MancietSAutomation of aseptic sterile preparation: risk analysis and productivity comparison with manual process20194152810.1515/pthp-2019-0001Open DOISearch in Google Scholar
Spivey S, Connor TH. Determining sources of workplace contamination with antineoplastic drugs and comparing conventional IV drug preparation with a closed system. Hosp Pharm 2003;38:135–9. doi: 10.1177/001857870303800SpiveySConnorTHDetermining sources of workplace contamination with antineoplastic drugs and comparing conventional IV drug preparation with a closed system200338135910.1177/001857870303800Open DOISearch in Google Scholar
Fleury-Souverain S, Nussbaumer S, Mattiuzzo M, Bonnabry P. Determination of the external contamination and cross-contamination by cytotoxic drugs on the surfaces of vials available on the Swiss market. J Oncol Pharm Pract 2013;20:100–11. doi: 10.1177/1078155213482683Fleury-SouverainSNussbaumerSMattiuzzoMBonnabryPDetermination of the external contamination and cross-contamination by cytotoxic drugs on the surfaces of vials available on the Swiss market2013201001110.1177/1078155213482683Open DOISearch in Google Scholar
Silva LSE, Machado CDSB, Linden R, Antunes MV, da Silva LC, Wayhs CAY, Capp E, Ness SLR. Residual contamination in antineoplastic drug packaging. J Oncol Pharm Pract 2023;29:1862–7. doi: 10.1177/10781552231151693SilvaLSEMachadoCDSBLindenRAntunesMVda SilvaLCWayhsCAYCappENessSLRResidual contamination in antineoplastic drug packaging2023291862710.1177/10781552231151693Open DOISearch in Google Scholar
Hilliquin D, Tanguay C, Bussières JF. External contamination of commercial containers by antineoplastic agents: a literature review. Eur J Hosp Pharm 2020;27:313–4. doi: 10.1136/ejhpharm-2018-001705HilliquinDTanguayCBussièresJFExternal contamination of commercial containers by antineoplastic agents: a literature review202027313410.1136/ejhpharm-2018-001705Open DOISearch in Google Scholar
Gilbert RE, Kozak MC, Dobish RB, Bourrier VC, Koke PM, Kukreti V, Logan HA, Easty AC, Trbovich PL. Intravenous chemotherapy compounding errors in a follow-up pan-Canadian observational study. J Oncol Pract 2018;14(5):e295-e303. doi: 10.1200/JOP.17.00007GilbertREKozakMCDobishRBBourrierVCKokePMKukretiVLoganHAEastyACTrbovichPLIntravenous chemotherapy compounding errors in a follow-up pan-Canadian observational study2018145e295e30310.1200/JOP.17.00007Open DOISearch in Google Scholar
Cotteret C, Secretan PH, Gilles-Afchain L, Rousseau J, Vidal F, Salguero-Hernandez G, Batista J, Valverde V, Guitton J, Cisternino S, Schlatter J. External contamination of antineoplastic drug vials: an occupational risk to consider. Eur J Hosp Pharm 2022;29:284–6. doi: 10.1136/ejhpharm-2020-002440CotteretCSecretanPHGilles-AfchainLRousseauJVidalFSalguero-HernandezGBatistaJValverdeVGuittonJCisterninoSSchlatterJExternal contamination of antineoplastic drug vials: an occupational risk to consider202229284610.1136/ejhpharm-2020-002440Open DOISearch in Google Scholar
Dugheri S, Mucci N, Bucaletti E, Squillaci D, Cappelli G, Trevisani L, Bonari A, Cecchi M, Mini E, Ghiori A, Tognoni D, Berti N, Alderighi F, Li Vigni N, Orlandi I, Arcangeli G. Monitoring surface contamination for thirty antineoplastic drugs: a new proposal for surface exposure levels (SELs). Med Pr 2022;73:383–96. doi: 10.13075/mp.5893.01288DugheriSMucciNBucalettiESquillaciDCappelliGTrevisaniLBonariACecchiMMiniEGhioriATognoniDBertiNAlderighiFLi VigniNOrlandiIArcangeliGMonitoring surface contamination for thirty antineoplastic drugs: a new proposal for surface exposure levels (SELs)2022733839610.13075/mp.5893.01288Open DOISearch in Google Scholar
Shaikh H, Murhammer J, Sorenson S, Cleppe J, Amelon E, Lam F. Formulation options for cyclophosphamide. Oncology Safety 2022 [displayed 10 September 2023]. Available at https://www.pppmag.com/article/2881ShaikhHMurhammerJSorensonSCleppeJAmelonELamFFormulation options for cyclophosphamide2022[displayed 10 September 2023]. Available at https://www.pppmag.com/article/2881Search in Google Scholar
US 2022/0296617 A1. Stable liquid formulations of cyclophosphamide and processed to prepare the same, 2022 [displayed 25 September 2023]. Available at
https://patents.google.com/patent/US20220296617A1/enUS 2022/0296617 A12022[displayed 25 September 2023]. Available at https://patents.google.com/patent/US20220296617A1/enSearch in Google Scholar
Liston DR, Davis M. Clinically relevant concentrations of anticancer drugs: a guide for nonclinical studies. Clin Cancer Res 2017;23:3489–98. doi: 10.1158/1078-0432.CCR-16-3083ListonDRDavisMClinically relevant concentrations of anticancer drugs: a guide for nonclinical studies20172334899810.1158/1078-0432.CCR-16-3083Open DOISearch in Google Scholar